No. 031
:
Mr. Speaker, the following questions will be answered today: Questions Nos. 102 to 104, 108, 111 and 114.
[Text]
Question No. 102--Mr. Dan Albas:
With regard to the government's announcement in the Speech from the Throne to create one million jobs through environmentally focused measures: (a) what sectors will these jobs be in, and how many jobs are expected to be created in each sector; (b) what is the breakdown of where these jobs are expected to be created by province or territory and municipal region; (c) what is the breakdown of the educational attainment required for these jobs; (d) what is the projected cost to create these jobs; (e) is it the government's intent to employ unemployed retail and hospitality workers to build green infrastructure; (f) what is the projected cost to retrain a million workers for these jobs; (g) what is the demographic balance of people who currently work in the green energy sector; (h) what is the demographic balance of people currently most unemployed due to the crisis; (i) will there be private sector investment to create these jobs or will it be solely government funding; (j) how long does the government anticipate it will take to train unemployed retail, hospitality, and entertainment workers to build green infrastructure; and (k) what is the projected cost of this training?
Mr. Irek Kusmierczyk (Parliamentary Secretary to the Minister of Employment, Workforce Development and Disability Inclusion, Lib.):
Mr. Speaker, the Speech from the Throne outlined the government’s intent to launch a plan to create over one million jobs to help restore employment to previous levels. The plan will use a range of tools, including direct investment in the social sector and infrastructure, immediate training to quickly skill up workers and incentives for employers to hire and retain workers.
This commitment is part of the government’s four-pillar foundation to help build a stronger and more resilient Canada, including, first, fight the pandemic and save lives; second, support people and businesses through this crisis; third, build back better by strengthening the middle class, supporting job creation and long-term competitiveness with clean growth; and fourth, stand up for who we are as Canadians by achieving progress on gender equality, walking the road of reconciliation and fighting discrimination of every kind.
This plan also builds on the Government of Canada’s immediate and decisive action to support Canadians and businesses facing hardship as a result of the pandemic. Programs such as the Canada emergency response benefit, or CERB, have provided millions of Canadians with the financial support they needed to get by. Other measures such as the Canada emergency wage subsidy, or CEWS, have provided support to Canadian businesses, helping them to avoid layoffs, rehire employees and create new jobs. Close to nine million Canadians were helped by the CERB and over 3.5 million jobs were supported by the wage subsidy.
This plan is already working. The Canadian economy had lost three million jobs at the peak of the COVID-19 economic impact. By September, the Canadian economy had recovered about 2.3 million jobs.
However, clearly more needs to be done. This is why, through the Speech from the Throne, the government laid out a solid economic recovery plan that will restore employment to previous levels and ensure Canadians return to work and thrive economically.
Question No. 103--Mr. Dan Albas:
With regard to the government's plan to declare single-use plastics as a harmful substance: (a) what is the timeline for implementing such a declaration; (b) has there been any analysis of the trade implications of such a declaration, and, if so, who conducted the analysis, and what were the findings; (c) has there been a job impact analysis prepared, and, if so, who conducted the analysis, and what were the findings; (d) if this plan is implemented, what are the projected job impacts in Canada's petrochemical industry; (e) were there consultations undertaken with the provinces on such a declaration, and, if so, what are the details; (f) what is the policy justification to use environmental protection legislation to ban a consumer good, which is regulated provincially; and (g) has a legal analysis been conducted to ensure the legality of such a declaration, and, if so, who conducted the analysis and what were the findings?
Hon. Jonathan Wilkinson (Minister of Environment and Climate Change, Lib.):
Mr. Speaker, regarding part (a) of the question, as required under section 332 of the Canadian Environmental Protection Act, 1999, CEPA, a draft order in council proposing to add “plastic manufactured items” to schedule 1 of CEPA was published in the Canada Gazette, part I, on October 9, 2020, for a 60-day public comment period. After the public comment period is complete, Health Canada and Environment and Climate Change Canada will review comments received and determine whether adjustments are needed to the draft order. A final order in council adding “plastic manufactured items” to schedule 1 will be published in Canada Gazette, part II, in 2021.
With regard to part (b) of the question, the “Cabinet Directive on Regulation” requires departments and agencies to ensure Canada’s international commitments are met when carrying out their regulatory activities, including in the area of international trade. In addition, the directive requires departments and agencies to analyze the potential positive and negative impacts of a proposed regulation and its feasible alternative options on Canadians, businesses, governments and the environment, and identify how impacts are distributed across the various parties.
A cost-benefit analysis was conducted for the draft order in council that proposes to add “plastic manufactured items” to schedule 1 of CEPA, and found that the addition of “plastic manufactured items” to schedule 1 would not, on its own, impose any regulatory requirements on businesses or other entities, and would therefore not result in any incremental compliance costs for stakeholders. The small business lens analysis concluded that the proposed order would have no associated impact on small business, as it does not impose any administrative or compliance costs on businesses. This can be found in the “Regulatory Impact Analysis Statement” accompanying the draft order in council in Canada Gazette, part I.
With regard to part (c) of the question, the “Cabinet Directive on Regulation” requires departments and agencies to examine the potential impacts on employment of a proposed regulation and its feasible alternative options on Canadians, businesses, governments and the environment, and identify how impacts are distributed across the various parties. A cost-benefit analysis was conducted for the draft order in council that proposes to add “plastic manufactured items” to schedule 1 of CEPA and found that the addition of “plastic manufactured items” to schedule 1 would not, on its own, impose any regulatory requirements on businesses or other entities, and would therefore not result in any incremental compliance costs for stakeholders. The small business lens analysis concluded that the proposed order would have no associated impact on small business, as it does not impose any administrative or compliance costs on businesses. This can be found in the “Regulatory Impact Analysis Statement” accompanying the draft order in council in Canada Gazette, part I.
Regarding part (d) of the question, any risk management measures developed using the enabling authorities provided by adding “plastic manufactured items” to schedule 1 of CEPA, including regulations prohibiting or restricting the use of certain single-use plastic items, will undergo all of the analysis required by the “Cabinet Directive on Regulations”, including analysis of benefits and costs. As the government is still consulting partners and stakeholders and is still developing an approach for prohibiting or restricting certain single-use plastic items, this level of analysis is not yet available. However, this detailed analysis will accompany any draft regulations published in Canada Gazette, part I.
Regarding part (e) of the question, the Government of Canada has been working closely with provinces and territories through the Canadian Council of Ministers of the Environment to develop and implement the strategy on zero plastic waste, which seeks to move Canada toward a circular economy for plastics, positioning the country as a leader in forward-looking and innovative waste prevention and management solutions.
Provinces and territories have been provided regular updates on the Government of Canada’s comprehensive agenda for achieving zero plastic waste through the CCME, which often serves a forum for exchanging information on federal, provincial and territorial initiatives. For example, at the latest CCME meeting in July 2020, federal, provincial and territorial ministers devoted a major portion of their meeting to sharing perspectives and strategies for a sustainable post-pandemic recovery. Provinces and territories were also provided with early copies of the discussion paper that was released on October 7 for their review, and federal officials presented on the integrated management approach to the CCME’s waste reduction and recovery committee in September 2020.
With regard to part (f) of the question, the Government of Canada’s approach is based on the best available science and evidence. The scientific basis is outlined in the “Science Assessment of Plastic Pollution”, developed jointly by Environment and Climate Change Canada and Health Canada. The science assessment confirms that, among other things, plastic items greater than five millimetres in diameter have been shown to cause harm to living organisms and their habitat. Wildlife ingest or become entangled in these plastics, which result in direct harm and, in many cases, mortality. The science assessment confirms that action is needed to reduce plastics that end up in the environment.
In addition, data from shoreline cleanups and municipal litter audits show that single-use plastics are prevalent in the environment and pose a threat to wildlife. With this basis of science and evidence, the Government of Canada has proposed using enabling authorities under CEPA to regulate certain single-use plastics. CEPA is an important part of Canada's federal environmental legislation aimed at preventing pollution and protecting the environment and human health. CEPA provides a range of tools that allows the government to target sources of plastic pollution and change behaviour at key stages in the life cycle of plastic products, such as design, manufacture, use, disposal and recovery, in order to reduce pollution and create the conditions for achieving a circular plastics economy.
Regarding part (g) of the question, the recommendation to add a substance to schedule 1 of the Canadian Environmental Protection Act, 1999, CEPA, is on the basis of the provisions outlined in CEPA. In particular, subsection 90(1) of CEPA authorizes the Governor in Council to add a substance to schedule 1 if it is satisfied, on the recommendation of the ministers of health and environment, that the substance meets any of the criteria set out in section 64 of the act, i.e., if the substance poses a risk to the environment, human health or both. The “Science Assessment of Plastic Pollution” provided the ministers with the evidence to recommend adding “plastic manufactured items” to schedule 1 of CEPA, an action that would help address the potential ecological risks associated with plastic manufactured items becoming plastic pollution.
Question No. 104--Mr. Eric Melillo:
With regard to the decision by the Federal Economic Development Initiative for Northern Ontario (FedNor) to provide a $800,000 loan to skritswap Inc.: (a) how many of the seven positions the government’s website claims will be created from the loan will be located (i) in Northern Ontario, broken down by location, (ii) in Canada, (iii) in the United States; (b) did the government verify that the company was actually primarily based out of Sault Ste. Marie as opposed to the company’s locations in Waterloo, Ontario, or San Mateo, California; (c) if the government did verify that the company had a permanent head office in Northern Ontario by visiting the location, which government official visited the location; (d) did FedNor receive a commitment from the company that any jobs created from the loan would be created in Northern Ontario, and, if so, what are the details of the commitment; and (e) what is the breakdown of the anticipated economic benefit or jobs being created by municipality?
Hon. Mélanie Joly (Minister of Economic Development and Official Languages, Lib.):
Mr. Speaker, the Government of Canada is committed to growing the economy in northern Ontario and creating good local jobs. The Federal Economic Development Initiative for Northern Ontario, or FedNor, has always been a key partner for entrepreneurs in northern Ontario and an integral part of the economic development of the region.
In this specific case, the funding was given to support a woman entrepreneur in growing her business in northern Ontario. FedNor is aware of this situation, is in contact with the business and will continue to monitor the situation closely. The business is fully aware that if it fails to meet the parameters set by the contribution agreement, it will need to immediately pay back the funds it received.
FedNor will continue to work closely and strategically with businesses and community partners to build a stronger northern Ontario.
Question No. 108--Ms. Michelle Rempel Garner:
With regard to changes or modifications made to the operations and alert systems of the Global Public Health Intelligence Network, since January 1, 2016: (a) what are the specific details of each change or modification, including (i) the description of change or modification, (ii) the date of the decision, (iii) the date the change came into effect, (iv) who recommended the change or modification, (v) the date the Office of the Minister of Health was notified; (vi) the date the Privy Council Office or the Prime Minister's Office was notified; (vii) the date on which the change was made public, if applicable; (b) for each change in (a), were other countries informed of the change and what are the details of each such instance, including (i) the date, (ii) notified countries, (iii) the summary of change; and (c) for each change in (a), was the World Health Organization notified, and, if so, on what date?
Mr. Darren Fisher (Parliamentary Secretary to the Minister of Health, Lib.):
Mr. Speaker, with regard to part (a) (i), (ii), (iii), (iv), from the program’s inception until late 2018, the Global Public Health Intelligence Network, GPHIN, alerts were identified and issued by the program’s analysts. The purpose of an alert is to direct international and Canadian subscribers to a particular media article without any summary or additional analysis. In the fall of 2018, the health security infrastructure branch, HSIB, began a review of program information products, including GPHIN alerts and their associated approval processes.
Following internal discussions, a decision was made to raise the approval level to HSIB’s vice-president in order to maintain awareness of the Public Health Agency of Canada’s, PHAC’s, senior officials concerning alerts being published by the system.
Approval of the GPHIN daily reports, which provides a comprehensive summary of multiple media articles, remained at the analyst level and so had no change. In September 2020, approval for alerts was set at the director level.
All other GPHIN information products, such as the GPHIN daily report, previously called the situational awareness section daily report, continue to be distributed directly from GPHIN to subscribers, including senior management at PHAC and other government departments.
At no time has GPHIN been directed to cease or slow its information gathering. Information-sharing activities continue to take place in a timely manner. GPHIN’s primary role as a global event-based surveillance system has remained unchanged, and its capacity has been enhanced over a number of years via collaborations with partners such as the National Research Council.
With regard to part (a) (v), (vi), (vii), and parts (b) and (c), the above changes were made internally to PHAC. There is no documentation indicating that the change in the approval process for GPHIN alerts was communicated to the organizations listed above.
Question No. 111--Ms. Michelle Rempel Garner:
With regard to the distribution of a COVID-19 vaccine: (a) what is the expected timeline for the distribution of a vaccine; (b) once the vaccine is approved by Health Canada, which population groups will be designated priority groups to receive the vaccine first; (c) what is the current time estimate to vaccinate all of the groups in (b), broken down by priority groups; (d) what is the current time estimate to give access to the general population once a vaccine is approved; (e) what is the current time estimate to vaccinate all Canadians who desire or require a vaccine; (f) what percentage of doses will be allocated to each of the initial priority groups; (g) what percentage of doses will be allocated to the general population; and (h) what criteria did the government use to determine which groups would receive priority access?
Mr. Darren Fisher (Parliamentary Secretary to the Minister of Health, Lib.):
Mr. Speaker, with regard to part (a), the Public Health Agency of Canada, PHAC, anticipates limited vaccine to be available for distribution in Canada in the first part of 2021. Any vaccine that is distributed in Canada must have regulatory approval or an interim order. The initial supply is expected to be constrained, improving over time as manufacturing is scaled up and the availability of products that have completed clinical trials are approved by Health Canada.
With regard to part (b), guidance on the use of a pandemic vaccine, including recommendations on key populations for early vaccination when initial vaccine supply is limited, has been provided by Canada’s National Advisory Committee on Immunization, NACI, an external expert advisory body that provides advice to PHAC on the optimal use of vaccines in Canada. NACI is identified in the federal, provincial and territorial Canadian pandemic plan as the authoritative body for advice on vaccine prioritization and vaccine public health program design.
On November 3, 2020, NACI released preliminary guidance on key populations for early COVID-19 immunization, with the goal of providing a plan for the efficient, effective and equitable allocation of a COVID-19 vaccine once it is authorized for use in Canada when limited initial vaccine supply will necessitate the prioritization of immunization in some populations earlier than others. This document can be found online at www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-key-populations-early-covid-19-immunization.html
Once a vaccine candidate has completed advanced clinical trials, NACI will refine and recalibrate its preliminary guidance on target groups, based on additional safety and efficacy data from advanced clinical trials; availability of supply; one- or multi-dose schedules; whether/how to vaccinate children and pregnant women; and policy frameworks regarding ethics, equity and economics.
With regard to part (c), at this time, a number of vaccines for COVID-19 are undergoing clinical testing in Canada and internationally and PHAC does not yet know which ones will prove safe and effective. In addition, significant uncertainty remains regarding the level and type of protection an approved vaccine might be able to induce in different population groups, e.g., age, underlying condition, previous infection, etc.. Until this information is known, PHAC cannot estimate the time it will take to vaccinate priority groups.
With regard to part (d), see response for part (a).
With regard to part e), see response for part (a).
With regard to part (f), once a vaccine candidate has completed advanced clinical trials, NACI will refine and recalibrate its preliminary guidance on target groups, based on additional safety and efficacy data from advanced clinical trials; availability of supply; one- or multi-dose schedules; whether/how to vaccinate children and pregnant women; and policy frameworks regarding ethics, equity and economics.
Provinces and territories, P/Ts, are responsible for the administration and delivery of health care services, including immunization-related programs. Immunization policies and schedules are developed by P/Ts or their expert immunization advisory committees, based on jurisdiction-specific needs, other immunization recommendations, such as NACI, program resource availability and constraints, and identified priorities. As such, each P/T will determine the percentage of doses that will be allocated to each of its initial priority groups.
With regard to part (g), see response for part (f).
With regard to part (h), NACI reviewed available evidence on the epidemiology and burden of COVID-19 to develop its preliminary guidance on priority immunization strategies with associated target groups. As noted, once a vaccine candidate has completed advanced clinical trials, NACI will refine and recalibrate its preliminary guidance on target groups, based on additional safety and efficacy data from advanced clinical trials; availability of supply; one- or multi-dose schedules; whether/how to vaccinate children and pregnant women; and policy frameworks regarding ethics, equity and economics.
Question No. 114--Mr. Arnold Viersen:
With regard to taxpayer money being used to sue the Conservative Party of Canada: what are the total legal fees and other related expenditures to date spent by CBC/Radio-Canada in relation to its ongoing lawsuit against the Conservative Party of Canada?
Ms. Julie Dabrusin (Parliamentary Secretary to the Minister of Canadian Heritage, Lib.):
Mr. Speaker, in processing parliamentary returns, the government applies the Privacy Act and the principles set out in the Access to Information Act. Information on the expenditures made in relation to the current civil litigation action against the Conservative Party of Canada has been withheld on the grounds that the information constitutes solicitor-client privilege.
:
Mr. Speaker, if a revised response to Question No. 79, originally tabled on November 16, 2020, and the government's responses to Questions Nos. 98 to 101, 105 to 107, 109, 110, 112 and 113, could be made orders for returns, these returns would be tabled immediately.
Some hon. members: Agreed.
[Text]
Question No. 79--Mr. Doug Shipley:
With regard to ministers and exempt staff members flying on government aircraft, including helicopters, since January 1, 2019: what are the details of all such flights, including (i) date, (ii) origin, (iii) destination, (iv) type of aircraft, (v) which ministers and exempt staff members were on board?
(Return tabled)
Question No. 98--Mr. Charlie Angus:
With regard to the handling of cases and claims pursuant to the Indian Residential Schools Settlement Agreement by the Department of Justice Canada, Indigenous Services Canada and Crown-Indigenous Relations and Northern Affairs Canada: how much has been spent on settled cases, requests for direction, and other proceedings where Canada has been either the plaintiff or defendant before appellate courts (such as the Ontario Superior Court or the Supreme Court of British Columbia) related to survivors of St. Anne's Residential School between 2013 and October 1, 2020, (i) in total, (ii) broken down by year?
(Return tabled)
Question No. 99--Mr. Charlie Angus:
With regard to federal funding in the constituency of Timmins—James Bay, between January 2019 and October 2020: (a) what applications for funding have been received, including for each the (i) name of the organization, (ii) department, (iii) program and sub-program under which they applied for funding, (iv) date of the application, (v) amount applied for, (vi) whether the funding has been approved or not, (vii) total amount of funding allocated, if the funding was approved; (b) what funds, grants, loans, and loan guarantees has the government issued through its various departments and agencies in the constituency of Timmins—James Bay that did not require a direct application from the applicant, including for each the (i) name of the organization, (ii) department, (iii) program and sub-program under which they received funding, (iv) total amount of funding allocated, if the funding was approved; and (c) what projects have been funded in the constituency of Timmins—James Bay by organizations tasked with subgranting government funds (e.g. Community Foundations of Canada), including for each the (i) name of the organization, (ii) department, (iii) program and sub-program under which they received funding, (iv) total amount of funding allocated, if the funding was approved?
(Return tabled)
Question No. 100--Mr. Richard Cannings:
With regards to federal expenditures in the electoral district of South Okanagan—West Kootenay, broken down by fiscal years 2018-19 and 2019-20: what were the total amounts spent by the federal government, broken down by the (i) department or agency, (ii) community, (iii) contribution agreement, (iv) purpose of spending?
(Return tabled)
Question No. 101--Mr. Richard Cannings:
With regard to the Softwood Lumber Action Plan announced on June 1, 2017, broken down by department or agency and contribution agreement: (a) what companies, organizations or communities have received funding; (b) how much has been received by each community, company or organization; (c) for what purpose has each contribution been used; (d) for each community, company or organization, how many people have been assisted; (e) have all of the original $867 million dollars been expended, and, if not, how much remains to be expended; and (f) have additional funds been allocated to this action plan or under other government initiatives to assist those negatively impacted by the tariffs put in place by the United States?
(Return tabled)
Question No. 105--Ms. Christine Normandin:
With regard to the activities of the Immigration and Refugee Board of Canada (IRB) during the pandemic: (a) for each of the IRB’s four divisions, broken down by month and for the Eastern, Central and Vancouver divisions, how many hearings were held during the months of April to September in (i) 2019, (ii) 2020; (b) broken down by month, how many refugee protection claims eligible for file review were processed during the months of April to August in (i) 2019, (ii) 2020; (c) between April and August 2020, how many members, as a percentage, received their full pay; (d) what work was required for members working for the IRB; (e) on what date did the IRB Registry and mail room resume processing claims received by mail and fax; (f) as of March 16, 2020, how many Refugee Protection Division (RPD), Refugee Appeal Division (RAD), Immigration Division (ID) and Immigration Appeal Division (IAD) files were pending (backlog) and what was the average time between referral and decision; (g) to date, how many RPD, RAD, ID and IAD files are awaiting a hearing; (h) to date, what is the average time between referral and decision; and (i) how many IRB employees have had vacation leave since the resumption of operations?
(Return tabled)
Question No. 106--Ms. Christine Normandin:
With regard to the activities of Immigration, Refugee and Citizenship Canada (IRCC) during the pandemic: (a) broken down by month, how many confirmations of permanent residence were issued during the months of April to August in (i) 2019, (ii) 2020; (b) broken down by month, how many visas (tourist, student, etc.) were issued during the months of April to August in (i) 2019, (ii) 2020; (c) to date, how many IRCC officers, as a percentage, received the necessary information equipment (telephones, computers, etc.) to enable them to work from home; (d) how many refugee protection claims were received by IRCC between March 17, 2020, and July 31, 2020, and of these, how many were referred to the Immigration and Refugee Board (IRB); and (e) what is the current processing time for permanent resident cards, and what was the processing time for the same period in 2019?
(Return tabled)
Question No. 107--Mr. Gabriel Ste-Marie:
With regard to federal public servants living in the National Capital Region (NCR): (a) how many public servants worked in the NCR between 2010 and 2019, inclusively, broken down by year and province of residence, and what percentage of public servants (i) lived in Quebec but worked in Ontario, (ii) lived in Ontario, but worked in Quebec, (iii) lived and worked in Ontario, (iv) lived and worked in Quebec; (b) for each year between 2010 and 2019, inclusively, what percentage of the public service payroll is represented by the wages of federal public servants living in the NCR and working in (i) Ontario, (ii) Quebec; and (c) for each year between 2010 and 2019, inclusively, what is the mother tongue of federal public servants living in the NCR and the language most often spoken at work, broken down by province of (i) residence, (ii) work?
(Return tabled)
Question No. 109--Ms. Michelle Rempel Garner:
With regard to the organization and structure of the Public Health Agency of Canada (PHAC): (a) what was the organizational structure of PHAC, including a breakdown of how many employees or full-time equivalents (FTEs) working in each branch, location and in each position, as of (i) January 1, 2016, (ii) October 1, 2020; and (b) what are the details of the positions that have been eliminated or modified since January 1, 2016, including the (i) previous job title, (ii) new job title, if applicable, (iii) previous job description, (iv) new job description, (v) number of positions impacted, (vi) date position was eliminated or modified, (vii) number of previous positions eliminated, if applicable?
(Return tabled)
Question No. 110--Ms. Michelle Rempel Garner:
With regard to drug products currently awaiting approval and market authorization by Health Canada: (a) what is the complete list of products currently awaiting approval; (b) for each product in (a), what was the (i) date the application was received by the government, (ii) manufacturer, (iii) product name, (iv) summary of product claims, including the list of diseases and conditions the product claims to treat, (v) expected date of decision of approval by Health Canada, if known; and (c) has the time period between the date of application and the decision date by Health Canada, for non-COVID-19 related products increased as a result of reallocating resources during the pandemic, and, if so, what are the specific details, including for which applications and for which products the time period has increased?
(Return tabled)
Question No. 112--Mr. Chris d'Entremont:
With regard to the organization and structure of Health Canada: (a) what was the organizational structure of Health Canada, including a breakdown of how many employees or fulltime equivalents (FTEs) working in each branch, location, and in each position, as of (i) January 1, 2016, (ii) October 1, 2020; and (b) what are the details of the positions that have been eliminated or modified since January 1, 2016, including the (i) previous job title, (ii) new job title, if applicable, (iii) previous job description, (iv) new job description, (v) number of positions impacted, (vi) date position was eliminated or modified, (vii) number of previous positions eliminated, if applicable?
(Return tabled)
Question No. 113--Mr. Tony Baldinelli:
With regard to the decision by VIA Rail to layoff workers during the pandemic: (a) what is the total number of workers laid off since March 1, 2020; (b) what is the number of layoffs broken down by date; (c) on what date did the minister responsible for VIA Rail become informed of plans for each of the layoffs in (b); (d) why did VIA Rail not use the Canada Emergency Wage Subsidy (CEWS) to prevent the layoffs; (e) will VIA Rail management and executives continue to receive bonuses in light of the layoffs; (f) what is the total amount of bonus money paid out so far in 2020; and (g) what is the total amount VIA Rail has received so far in 2020 through (i) CEWS, (ii) other sources of government funding, broken down by source?
(Return tabled)
[English]
:
Mr. Speaker, I would ask that all remaining questions be allowed to stand at this time.
Some hon. members: Agreed.
Order Paper Question No. 97